BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 21, 2025 | $1,303,000 | Replaced |
| 1st Quarter - Amendment | Oct 14, 2025 | $1,438,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALLY GUTHRIE | — |
| JESSICA JOHNSTON | — |
| ADAM LOTSPIKE | — |
| ISABEL OMER New | — |
| TODD SPANGLER | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate taxation Tax incentives for domestic manufacturing
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALLY GUTHRIE | — |
| ADAM LOTSPIKE | — |
| ISABEL OMER New | — |
| TODD SPANGLER | — |
Budget/Appropriations BUD
Issues related to medical device supply chains and supply chain resiliency Issues related to medical research funding Issues related to medical device sterilization
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALLY GUTHRIE | — |
| ADAM LOTSPIKE | — |
| ISABEL OMER New | — |
| TODD SPANGLER | — |
Trade (domestic/foreign) TRD
Issues related to medical device supply chain
| Lobbyist | Covered position, as disclosed |
|---|---|
| SALLY GUTHRIE | — |
| JESSICA JOHNSTON | — |
| ADAM LOTSPIKE | — |
| ISABEL OMER New | — |
| TODD SPANGLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.